O'Shaughnessy Asset Management’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.07M | Sell |
369,503
-4,399
| -1% | -$45.6K | 0.02% | 697 |
|
|
2025
Q4 | $4.62M | Buy |
373,902
+225,918
| +153% | +$2.42M | 0.03% | 537 |
|
|
2025
Q3 | $1.31M | Buy |
+147,984
| New | +$1.15M | 0.01% | 1013 |
|
|
2022
Q4 | – | Sell |
-28,711
| Closed | -$603K | – | 1410 |
|
|
2022
Q3 | $603K | Buy |
+28,711
| New | +$799K | 0.01% | 674 |
|
|
2021
Q4 | – | Sell |
-103
| Closed | -$5K | – | 1584 |
|
|
2021
Q3 | $5K | Sell |
103
-2,795
| -96% | -$169K | ﹤0.01% | 2321 |
|
|
2021
Q2 | $182K | Sell |
2,898
-3,518
| -55% | -$226K | ﹤0.01% | 1073 |
|
|
2021
Q1 | $596K | Sell |
6,416
-7,067
| -52% | -$724K | 0.01% | 548 |
|
|
2020
Q4 | $1.21M | Sell |
13,483
-1,505
| -10% | -$138K | 0.03% | 302 |
|
|
2020
Q3 | $1.55M | Buy |
14,988
+5,912
| +65% | +$637K | 0.05% | 215 |
|
|
2020
Q2 | $719K | Buy |
9,076
+7,532
| +488% | +$561K | 0.02% | 329 |
|
|
2020
Q1 | $90K | Buy |
1,544
+1,414
| +1,088% | +$81.5K | ﹤0.01% | 647 |
|
|
2019
Q4 | $7K | Sell |
130
-4,416
| -97% | -$240K | ﹤0.01% | 1375 |
|
|
2019
Q3 | $238K | Sell |
4,546
-1,624
| -26% | -$75.7K | 0.01% | 501 |
|
|
2019
Q2 | $297K | Sell |
6,170
-2,809
| -31% | -$135K | 0.01% | 470 |
|
|
2019
Q1 | $451K | Sell |
8,979
-10,020
| -53% | -$591K | 0.01% | 380 |
|
|
2018
Q4 | $1.13M | Hold |
18,999
| – | – | 0.03% | 238 |
|
|
2018
Q3 | $1.24M | Hold |
18,999
| – | – | 0.03% | 237 |
|
|
2018
Q2 | $953K | Buy |
18,999
+65
| +0.3% | +$3.39K | 0.02% | 255 |
|
|
2018
Q1 | $997K | Buy |
18,934
+14,457
| +323% | +$721K | 0.02% | 252 |
|
|
2017
Q4 | $208K | Buy |
+4,477
| New | +$188K | ﹤0.01% | 524 |
|
|
2017
Q1 | – | Sell |
-1,618
| Closed | -$53K | – | 896 |
|
|
2016
Q4 | $53K | Sell |
1,618
-6
| -0.4% | -$180 | ﹤0.01% | 707 |
|
|
2016
Q3 | $51K | Sell |
1,624
-562
| -26% | -$16.3K | ﹤0.01% | 689 |
|
|
2016
Q2 | $61K | Sell |
2,186
-2,028
| -48% | -$79.5K | ﹤0.01% | 667 |
|
|
2016
Q1 | $148K | Buy |
4,214
+1,677
| +66% | +$59.2K | ﹤0.01% | 501 |
|
|
2015
Q4 | $102K | Buy |
+2,537
| New | +$88.5K | ﹤0.01% | 551 |
|
|
2015
Q1 | – | Sell |
-27,727
| Closed | -$751K | – | 1039 |
|
|
2014
Q4 | $751K | Sell |
27,727
-48,946
| -64% | -$1.17M | 0.01% | 354 |
|
|
2014
Q3 | $1.63M | Sell |
76,673
-2,286
| -3% | -$52.3K | 0.03% | 275 |
|
|
2014
Q2 | $1.77M | Buy |
78,959
+41,995
| +114% | +$978K | 0.03% | 269 |
|
|
2014
Q1 | $932K | Buy |
+36,964
| New | +$934K | 0.02% | 334 |
|
Other funds holding EBS
VCM
PCM
VPM
O'Shaughnessy Asset Management's EBS Position: Q1 2026 in Review
O'Shaughnessy Asset Management reduced its Emergent Biosolutions (EBS) stake by 1.2% in Q1 2026, selling an estimated $45.6K and leaving 369,503 shares worth $3.07M. The position accounts for 0.02% of the portfolio, ranked #697.
O'Shaughnessy Asset Management first reported a position in EBS in Q1 2014 and has held it in 29 quarters since. The position peaked at $4.62M in Q4 2025. 190 funds tracked by Wall St. Rank hold EBS as of Q1 2026.
- O'Shaughnessy Asset Management held 369,503 shares of Emergent Biosolutions worth $3.07M as of Q1 2026.
- O'Shaughnessy Asset Management sold 4,399 Emergent Biosolutions shares in Q1 2026, an estimated $45.6K.
- Emergent Biosolutions made up 0.02% of O'Shaughnessy Asset Management's portfolio in Q1 2026, its #697 holding.
- O'Shaughnessy Asset Management first reported a position in Emergent Biosolutions in Q1 2014 and has held it in 29 quarters since.
- O'Shaughnessy Asset Management's Emergent Biosolutions position peaked at $4.62M in Q4 2025.
- 190 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q1 2026.
Based on O'Shaughnessy Asset Management's 13F filing for Q1 2026, filed 13 May 2026.